Additional file 9: Figure S7. of Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis

Association between transplant modalities and outcomes for AML patients with pre-transplantation MRD who underwent allo-SCT, stratified by the level of leukemic cells. Estimates of (A) cumulative incidence of non-relapse mortality, (B) cumulative incidence of relapse, (C) leukemia-free survival, and overall survival. (DOCX 520 kb)